Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Euro Genetic Engineering 2020

Euro Genetic Engineering 2020

Conference Series LLC Ltd organizes conferences around the world on all medical subjects including Genetic Disorders and its related fields. Here we are happy to invite all Genetic researchers/ industrialists/ students to join our “New Frontiers on Genetic Research & Advanced Techniques"scheduled to be held in Tokyo, Japan during December 14-15, 2020. 

Details of Euro Genetic Engineering 2020, Tokyo, Japan.

Conference Name

Place

Date

Euro Genetic Engineering 2020

Tokyo, Japan.

December 14-15, 2020

 

About Conference


We invite all the participants across the world to attend the "New Frontiers on Genetic Research & Advanced Techniques" December 14-15, 2020 Tokyo, JapanThe theme of the conference is “Exploring Current Challenges in cells and gene therapy” and to encourage young minds and their research abilities by providing an opportunity to meet the experts in the field of Euro Genetic Engineering 2020.

Genetic Engineering, also called recombinant DNA technology, involves the group of techniques used to cut up and join together genetic material, especially DNA from different biological species, and to introduce the resulting hybrid DNA into an organism in order to form new combinations of heritable genetic materials. Genetics is an emerging group of sciences, which involves medicine, genetic engineering, and other biological sciences. Disorders in gene composition, called mutation may result in genetic disorders that need gene therapy treatment. Failure of treatment succeeds the mutant genes to offspring’s causing hereditary diseases or disorders.

Why to attend Genetic Engineering Conference?
Euro Genetic Engineering 2020 anticipates hundreds of delegates including international keynote lectures and oral presentations by renowned speakers and poster presentations by students, Exhibitions, and delegates all around the world which will craft a platform for global promotion and effective development in this field. It provides international networking and opportunities for collaborations with worldwide companies and industries Genetic Engineering Meetings
This global event will be an excellent opportunity for the Genetic Engineering Scientists and other professionals. We are anticipating around 100+ speakers and over 200 delegates for this esteemed Congress. Euro Genetic Engineering 2020.
Key Figures of Genetic Research 2020 | Tokyo
This international conference provides the opportunity for clinicians, scientists, doctors and researchers from all over the world to gather and learn the latest advances in the field of Genetic Engineering and healthcare and to exchange scientific ideas and experiences in a distinctive environment.
2 days of scientific exchange
200+ abstracts submitted
24+ scientific sessions
80+ international expert faculty members
100+ healthcare professionals
Euro Genetic Engineering 2020 is the annual meeting conducted with the support of the Organizing Committee Members and members of the Editorial Board of the supporting Genetic Engineering related journals and is aimed at helping support healthcare professionals i.e. Transhumanists, Surgeons, Perfusionists to deliver the best care possible to patients with Genetic  diseases.

 

Visa Assistance

Issue with VISA!!

Are you planning to have a professional and delightful trip to Tokyo, Japan???

We believe you must be having a query regarding your VISA to Visit as a Speaker/Delegate, Tourist or Business Person to Tokyo, Japan. Euro Genetic Engineering 2020 Committee will be happy to help you in all regards to plan your trip to the most historic place Tokyo. Here is the simplest way to know the process for your Visa Approval. Kindly register for the conference at the earliest and drop us an email at [email protected] and avail the official invitation letter from us and attend this event ahead with a closer step for approval of your VISA.
Register/enroll here to get an official invitation letter: https://geneticsengineering.insightconferences.com/registration.php

Processing time for VISA applications may vary depending on the office and the time of the year. Delegates/Attendees are encouraged to submit their visa applications well in advance of the date of the event at a VISA Application Centre or online E-applications, including all supporting documents.
Visa letters should only be issued to:
People the committee knows
Speakers/Presenters
Committee members
Attendees who have paid their registration fee in full or as decided by the committee members Visa letters should state the following facts
Conference title, dates and location
That the requester has paid the required registration fee in full
Verify that the credit card clears before providing letter
If they are either a committee member, speaker or presenter.

To simplify the request process for the attendees and organizers you need to request for visa letters for the conference once you are done with registration. Official invitation letter along with payment receipt will be mailed to you within 24-48 hours of your confirmation.

 

Market Analysis

Genetic Engineering Market Synopsis:
Genetic Engineering 2020  is a relatively newer concept in medical science being researched upon for discovery of treatments and drugs. Market Research Future (MRFR) has assessed in its latest report that the global Genetic Engineering Market is expected to mark a robust CAGR of 14.5% over the projection period 2018 to 2027. Pharmaceutical and biotechnology companies are investing in genetic manipulation which is anticipated to accelerate revenue growth for the market participants. In addition, the extensive use of gene therapy for clinical trials is projected to support the expansion of the global genetic engineering market in the forthcoming years. Technological innovations are likely to unleash strong developmental opportunities to the market. The developments and increasing use of technologies such as CRISPR/Cas9, TALEN, and ZNF are poised to dictate the growth pattern of the genetic engineering market over the next couple of years. Also, increasing burden of diseases such as cancer is expected to accelerate demand for genetic engineering in the years to come.

The prominent players of the global Genetic Engineering market profiled in this MRFR report are

  • Thermo Fisher Scientific Inc. (US)
  • Horizon Discovery Group Plc. (UK)
  • Genscript Biotech Corporation (US)
  • Transposagen Biopharmaceuticals Inc. (US).
  • Merck KGaA (Germany)
  • New England Biolabs (U.S)
  • Lonza Group Ltd. (Switzerland)
  • Origene Technologies Inc. (US)
  • Integrated DNA Technologies Inc. (US)
  • Genentech, Inc. (US)
  • Amgen Inc.(US)
  • Sangamo Therapeutics Inc. (US)

Genetic Engineering Industry News

In June 2019, Bluebird Bio,a Biotechnology company, has received approval in Europe for its one-time gene therapy – Zynteglo, for treating beta thalassemia.
In May 2019, the U.S. Food and Drug Administration (FDA) innovative gene therapy for pediatric patients, Zolgensma (onasemnogene abeparvovec-xioi), for treating spinal muscular atrophy (SMA), one of the leading causes of infant mortality.
In May 2019, researchers at the University of Maryland have genetically modified fungus to kill mosquitoes that are responsible for spreading malaria.

Market Segmentation : Global Gene Editing Market
The Market Research Future report provides an all-inclusive segmental analysis of the gene editing market on the basis of end users, methods, and applications.
By methods, the gene editing market is segmented into antisense technology, zinc finger nucleases (ZFN), transcription activator-like effector nucleases (TALEN), clustered regularly interspaced short palindromic repeats (CRISPR), and others.
By application, the gene editing market is segmented into gene therapy, microorganism’s genetic engineering, animal genetic engineering, and plant genetic engineering. Of these, the animal genetic engineering segment will lead the market during the forecast period for the extensive use of gene editing to modify the animal’s genome sequence.
By end users, the gene editing market is segmented into pharmaceuticals, biotechnology, and contract research organizations. Of these, pharmaceuticals and biotechnology will have maximum shares in the market during the forecast period for increasing use of gene editing in drug discovery and therapeutics.

 

Scientific Sessions

Track 1: Current Genetic Engineering Discoveries

Genetic engineering, also called recombinant DNA technology, involves the group of techniques used to cut up and join together genetic material, especially DNA from different biological species, and to introduce the resulting hybrid DNA into an organism in order to form new combinations of heritable genetic material. Genetic engineering has been applied in numerous fields including research, medicine, industrial biotechnology and agriculture. Many more new discoveries are invented in the Genetic Research. But the few Recent Discoveries in Genetic Engineering,

  1. GM Mosquito Progeny Not Dying in Brazil: Study:
  2. Timing and Order of Molecular Events Recorded in Live Cells’ DNA
  3. FDA Lifts Import Restrictions on Genetically Engineered Salmon
  4. Gene Drive–Equipped Mosquitoes Released into Lab Environment
  5. Better Base Editing in Plants
  6. Info graphic: Plant Genome Editors Get A New Tool
  7. Opinion: GE Crops Are Seen Through a Warped Len

Conference on Genetic Research | Genetic Engineering Conference | Genetically Modified Conference | DNA Conference | Current Discoveries Conference 

Track 2: Genetically Modified Crops and Food

Crops: Genetically modified crops (GM crops) are plants used in agriculture, the DNA of which has been modified using genetic engineering methods. In most cases, the aim is to introduce a new trait to the plant which does not occur naturally in the species. Examples in food crops include resistance to certain pests, diseases, environmental conditions, reduction of spoilage, resistance to chemical treatments (e.g. resistance to a herbicide), or improving the nutrient profile of the crop. Examples in non-food crops include production of pharmaceutical agents, biofuels, and other industrially useful goods, as well as for bioremediation.
Food: Genetically modified foods (GM foods), also known as genetically engineered foods (GE foods), or bioengineered foods are foods produced from organisms that have had changes introduced into their DNA using the methods of genetic engineering. Genetic engineering techniques allow for the introduction of new traits as well as greater control over traits when compared to previous methods, such as selective breeding and mutation breeding.

Conference on Genetically Modified Crops | Conferences on Genetically modified food | Conferennce on Genetic Engineering | Summit on Genetic Research | Conference on DNA 

Track 3: Gene Therapy, IVF, Stem Cells, and Pharmacogenomics

Gene Therapy: Human DNA is estimated to have approximately 12 million single nucleotide polymorphisms (SNPs) and thousands of copy number variants (CNVs), most of which are not harmful. However, genetic disorders do sometimes occur as a result of mutations that alter or inhibit protein function. Gene therapy focuses on correcting these mutated or defective genes by way of the following techniques:

  • Random insertion of a normal gene into the genome (most common technique)
  • Replacement of the abnormal gene with a normal one
  • Repair of the abnormal gene
  • Altering regulation of a particular gene.

IVF: The in vitro fertilization (IVF) "miracle" of the late 1970s occurred five years before the polymerase chain reaction revolutionized the field of genetics, 18 years before the first bacterial genome was sequenced, and 26 years before completion of the human genome sequence.
Stem Cell Therapy: Beyond gene therapy, another issue of much debate relates to the use of stem cells. These cells can be divided into two broad classes: embryonic and adult. Both classes are currently being explored for possible therapeutic applications.
Pharmacogenomics: Today, the field of personalized medicine makes use of pharmacogenomics, or the science that predicts a person's response to a drug based upon that person's genetic makeup. Indeed, the U.S. Food and Drug Administration (FDA) signaled its commitment to personalized medicine with the decision to add a warning to the label of a widely used blood thinner stating that response to the drug might be influenced by a person's genetic makeup.
Conference on Gene Therapy| Conference on Genetic Research | Conference on Genetic Engineering | Conference on Pharmacogenomics | Conference on Cell Therapy 

Track: 4 Genetic Change and Mutations

A gene mutation is a permanent alteration in the DNA sequence that makes up a gene, such that the sequence differs from what is found in most people. Mutations range in size; they can affect anywhere from a single DNA building block (base pair) to a large segment of a chromosome that includes multiple genes. Mutation in the DNA of a body cell of a multicellular organism (somatic mutation) may be transmitted to descendant cells by DNA replication and hence result in a sector or patch of cells having abnormal function, an example being cancer.

Conference On Genetic Mutation | Genetic Mutation Conferences | Genetically Modified Conference | Conference on Genetic Research | conference on Genetic Engineering 

Track: 5 Molecular Cloning and Gene Delivery

Molecular cloning: It is a set of experimental methods in molecular biology that are used to assemble recombinant DNA molecules and to direct their replication within host organisms.The use of the word cloning refers to the fact that the method involves the replication of one molecule to produce a population of cells with identical DNA molecules. Molecular cloning generally uses DNA sequences from two different organisms: the species that is the source of the DNA to be cloned, and the species that will serve as the living host for replication of the recombinant DNA.
Gene Delivery: Gene delivery is the process of introducing foreign genetic material, such as DNA or RNA, into host cells. Genetic material must reach the nucleus of the host cell to induce gene expression. Successful gene delivery requires the foreign genetic material to remain stable within the host cell and can either integrate into the genome or replicate independently of it.

Conference on Molecular Cloning | Conference On Gene Delivery | Conference on Genetic Research | Conference on Genetic Engineering | Conference on Cell Enzyme 

Track: 6 Genetically Modified Organisms

A genetically modified organism (GMO) is any organism whose genetic material has been altered using genetic engineering techniques. A wide variety of organisms have been genetically modified (GM), from animals to plants and microorganisms. People have been altering the genomes of plants and animals for many years using traditional breeding techniques. Agricultural plants are one of the most frequently cited examples of genetically modified organisms (GMOs). Some benefits of genetic engineering in agriculture are increased crop yields, reduced costs for food or drug production, reduced need for pesticides, enhanced nutrient composition and food quality, resistance to pests and disease, greater food security, and medical benefits to the world's growing population.

Conference on Geneticall Modified Organism | Genetic Research Meeting | Conference on Genetic Engineering | Conference on Gene therapy | Conference on cell Enzyme 

Track: 7  Plasmid Architecture and Vector

Plasmids are made up of circular double chains of DNA. The circular structure of plasmids is made possible by the two ends of the double strands being joined by covalent bonds. Although a good number of plasmids have a covalently closed circular structure, some plasmids have a linear structure and do not form a circular shape.

Types of Plasmids: 

  1. Resistance Plasmids
  2. Degradative Plasmids
  3. Fertility Plasmids
  4. Col Plasmids
  5. Virulence Plasmids

Vector: A vector refers to any piece of molecule that contains genetic material that can be replicated and expressed when transferred into another cell.

Conference on Plasmid Vector | Genetic Engineering Conference | Conference on Genetic Research | Conference on DNA | conference on Gene Therapy | Conference on Plamid Vector 

Track: 8 Drug Discovery Technologies

Powerful new instruments and biotechnology related scientific disciplines (genomics, proteomics) make it possible to examine and exploit the behavior of proteins and molecules. Recombinant DNA (rDNA) technologies (genetic, protein, and metabolic engineering) allow the production of a wide range of peptides, proteins, and biochemicals from naturally nonproducing cells. This technology, now approximately 25 years old, is becoming one of the most important technologies developed in the 20(th) century.

Conference on Drug Discoveries |Genetic Research Conference | Conference on Genomics | Conference on Proteomics | Conference on Genetic Engineering | DNA conference

Track: 9 Clinical Genetics

Clinical genetics involves the study, counseling and treatment of individuals and families with heritable disorders and disease predisposition. Diagnostic tools include standard ontologies for describing dysmorphology and traits, pedigree analysis, disease locus mapping by linkage or homozygosity, karyotyping, genome sequencing and genotyping.

Conference on Clinical Genetics | Genetic Research Conference | Conference on Genetic Research | Conference on genetic Engineering | Conference on Genomics 

Track: 10 DNA Fingerprint

DNA fingerprinting or DNA profiling is a method used to identify an individual from a sample of DNA by looking at unique patterns in their DNA. DNA profiling is a forensic technique in criminal investigations, comparing criminal suspects' profiles to DNA evidence so as to assess the likelihood of their involvement in the crime.

Conference on DNA fingerprint | Genetic Engineering Conference | Conference on Genetic Research | Conference on Genomics | Conference on DNA 

Track: 11 Genetic Diagnosis and Disease Risks

Preimplantation genetic diagnosis (PGD) followed by implantation of unaffected embryos offers high-risk couples the option to decrease the risk of genetic disease in their offspring without the dilemma of a prenatal diagnosis that may be followed by a termination of pregnancy.

Conference on Genetic Diagnosis | Genetic Research conference | Conference on Genetic Engineering | Conference on Genomics | conference on Cell Enzyme 

Track: 12 CRISPR Gene Editing

CRISPR is a type of gene-editing technology that lets scientists more rapidly and accurately 'cut' and 'paste' genes into DNA. It is based on a targeted DNA-destroying defense system originally found in certain prokaryotes. CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats, a term that describes a family of nucleic acid sequences that were discovered in archaea and bacteria in the 1990s containing copies of virus genes. This ability to identify specific DNA sequences with precision and break them apart was quickly recognized as a perfect tool for editing genes.

Conference on Gene Editing | Genetic Editing Conference | Conference on CRISPR | Conference on Genomics | Conference on Cell Therapy 

Track: 13 Stem Cells and Cloning

Stem cells are undifferentiated or unspecialized cells without a specific function because they have not yet changed into specific tissue cells. Stem cells are different to other body cells because during division they present the following characteristics:

  1. They produce new copies of themselves indefinitely.
  2. They produce new cells that under the right stimuli can develop into different tissues of which the human body is composed of.
  3. They can colonies and repair sick tissues or organs, replacing sick cells with healthy cells.

Cloning is a set of laboratory methods and techniques that allows us to reproduce any biological material as many times as we want, specifically cells, DNA, etc. We could say that cloning is the same as photocopying, that is, to make as many identical copies of something as we need. ery easily, what we want to clone are very special cells called stem cells.

Conference on Stem Cells | Conference on Cloning | Conference on Gene Therapy | Conference on Genetic Research | Genetic Engineering Conference 

Track: 14 Industrial Biotechnology

Industrial biotechnology, also known as white biotechnology, is the modern use and application of biotechnology for the sustainable processing and production of chemicals, materials and fuels from renewable sources, using living cells and/or their enzymes. This field  is widely regarded as the third wave of biotechnology, distinct from the first two waves (medical or red biotechnology and agricultural or green biotechnology).

Conference on Industrial Biotechnology | Conference on Genetic Research | Conference on Biotechnology | Conference on Genetic Engineering | Conference on Cell Therapy 

Track: 15 Medicinal Biotechnology

Medicinal biotechnology aims to produce pharmaceutical and diagnostic products for the prevention and treatment of human diseases using living cells and cell materials. The areas of application of medicinal biotechnology are genetic testing, drug production, gene therapy and pharmacogenomics. One of the major uses in biotechnology is for medicinal purposes. Modern applications of biotechnology continue to find promising new uses in the medicinal and health care fields.

Conference on Medicinal Biotechnology | Conference on Genetic Research | Genetic Modified Conference | Conference on Genetic Engineering | Conference on Cell Therapy 

To Collaborate Scientific Professionals around the World

Conference Date December 14-15, 2020

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

Journal of Genetics and DNA Research Journal of Molecular and Genetic Medicine Human Genetics & Embryology Journal of Genetic Disorders & Genetic Reports

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by